To boost its cardiovascular pipeline, Novartis has announced the acquisition of the company it co-founded with Blackstone ...
1 天
DPA International on MSNNovartis to buy Anthos Therapeutics in $3.1 bn dealSwiss pharmaceutical firm Novartis said on Tuesday that it has agreed to buy privately held, clinical-stage US biotech Anthos ...
Nike returned to the Super Bowl after nearly 30 years with a 90-second spot “So Win” featuring WNBA stars Caitlin Clark, A’ja ...
BASEL, Switzerland I 11, 2025 I Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, ...
Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...
Novartis started a review of the business in October 2021, after Sandoz had been suffering from pressure on sales and operating profits for several years due mainly to pricing pressures ...
Novartis’ Kymriah is to receive fast reviews in the US and EU for a new use in a form of aggressive non-Hodgkin lymphoma, in a move that brings it into direct competition with Gilead's rival.
The acting chair of the, Mark Uyeda, took the first step Tuesday to rolling back a rule that would require thousands of ...
Novartis has acquired exclusive global rights to GenVec's preclinical hearing loss and balance disorders programme. The programme has been investigating gene therapy to express atonal homologue 1 ...
6 天
Zacks.com on MSNNovartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?Swiss pharma giant Novartis NVS reported better-than-expected fourth-quarter 2024 results, wherein both earnings and revenues beat estimates. Core earnings (excluding one-time charges) of $1.98 per ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果